Cargando…

Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission

Detalles Bibliográficos
Autores principales:	Guo, Kai-heng, Zhou, Xiao-ying, Zeng, Chun-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644800/ https://www.ncbi.nlm.nih.gov/pubmed/38027215 http://dx.doi.org/10.3389/fendo.2023.1325071

Ejemplares similares

The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events
por: Kassem, Mahmoud Attia Mohamed, et al.
Publicado: (2017)

Characterization of Post-Hypoglycemic Hyperglycemia in Children and Adolescents With Type 1 Diabetes: The EPHICA Study
por: Colinet, Victoria, et al.
Publicado: (2022)

An Uncommon Case of Recurrent Hypoglycemic Episodes in a Healthy Non-diabetic Male: Insulin Autoimmune Syndrome
por: Dhaliwal, Kanwarpal K, et al.
Publicado: (2023)

Remission of type 2 diabetes: A critical appraisal
por: Ricci, Michele, et al.
Publicado: (2023)

Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score
por: Nwosu, Benjamin Udoka
Publicado: (2022)

Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery
por: Pérez-Pevida, Belén, et al.
Publicado: (2019)

The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation
por: Tang, Rong, et al.
Publicado: (2019)

Predictors of consciousness improvement in patients with hypoglycemic encephalopathy
por: Lee, Yu Eun, et al.
Publicado: (2022)

Long-term remission of type 2 diabetes after very-low-calorie restriction and related predictors
por: Wei, Jie, et al.
Publicado: (2022)

Editorial: Insulin and The Brain
por: Taouis, Mohammed, et al.
Publicado: (2019)

Editorial: Cell Transplantation in Diabetes: Cell-Based Immunotherapy for Type 1 Diabetes
por: Wei, Lingling, et al.
Publicado: (2022)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
por: Yang, Chun-Ting, et al.
Publicado: (2022)

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Khayyat, Yara A, et al.
Publicado: (2022)

Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
por: Shi, Mei, et al.
Publicado: (2022)

The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy
por: Lei, Chunyan, et al.
Publicado: (2022)

Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies
por: Abdelrahim, Dana, et al.
Publicado: (2021)

Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
por: Zhang, Ying, et al.
Publicado: (2014)

Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
por: Tyurenkov, Ivan N., et al.
Publicado: (2018)

Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus: a retrospective observational study
por: Chen, Shuang, et al.
Publicado: (2023)

Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Editorial: Physical Activity and Type 1 Diabetes
por: Jendle, Johan H., et al.
Publicado: (2019)

Editorial: Insulin resistance and cardiovascular disease
por: Stewart, Alan J., et al.
Publicado: (2023)

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Interpetrosal sphingosine-1-phosphate ratio predicting Cushing’s disease tumor laterality and remission after surgery
por: Sun, Heng, et al.
Publicado: (2023)

Editorial: Revisiting cellular metabolism and type 1 diabetes
por: Chandra, Vikash, et al.
Publicado: (2023)

Adherence to Hypoglycemic Medication among Insulin-Treated Patients with Type 2 Diabetes
por: Zarei-Shargh, Parisa, et al.
Publicado: (2017)

Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial
por: Zaghlol, Louay Y., et al.
Publicado: (2021)

Editorial: Non-coding RNA in diabetes and cardiovascular diseases
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

Hypoglycemic effect of triphala on selected non insulin dependent Diabetes mellitus subjects
por: Rajan, Sowmya S., et al.
Publicado: (2008)

Editorial: Emerging talents in clinical diabetes
por: Matafome, Paulo, et al.
Publicado: (2023)

Body mass index and partial remission in 119 children with type 1 diabetes—a 6-year observational study
por: Sokołowska-Gadoux, Magdalena, et al.
Publicado: (2023)

Eligibility and Awareness Regarding Metabolic Surgery in Patients With Type 2 Diabetes Mellitus in the Real-World Clinical Setting; Estimate of Possible Diabetes Remission
por: Koliaki, Chrysi, et al.
Publicado: (2020)

Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials
por: Li, Yijun, et al.
Publicado: (2022)

Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
por: Khamis, Abeer M
Publicado: (2023)

Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes
por: Li, Xia, et al.
Publicado: (2023)

Editorial: Optimizing Exercise for the Prevention and Treatment of Type 2 Diabetes
por: Karstoft, Kristian, et al.
Publicado: (2018)

Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
por: Brusko, Todd M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igh4t6n37lt36foovbutkov8fs